Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT06991387
Recruiting Not applicable

Acute Effects of Myofascial Release in Individuals With Text Neck Syndrome

NCT06991387 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-05-10
Last updated
2025-06-05

Condition(s) studied

Text Neck PostureNeck PainMyofascial Release Technique

Investigational drug(s) / intervention(s)

Myofascial Release

Myofascial Release: A single session of myofascial release techniques including Single Arm Pull, Lateral Neck Shoulder Release, Thoracic Transverse Release, and Anterior Cervical Release applied by a physiotherapist trained in manual therapy.

Study summary

This study aims to investigate the acute effects of myofascial release therapy on neck pain, functional status, and cervical range of motion in individuals diagnosed with Text Neck Syndrome (TNS). Text Neck Syndrome is increasingly prevalent due to excessive use of smartphones and other digital devices, particularly among young adults. The intervention will consist of a single session of standardized myofascial release techniques applied to the cervical and thoracic regions. The primary outcome will be neck pain intensity measured using the Numeric Rating Scale (NRS-11), while secondary outcomes will include cervical range of motion and the modified Neck Disability Index (NDI). Assessments will be performed immediately before and after the intervention. The study will be conducted with volunteer participants between the ages of 18 and 40, who use mobile devices for more than 3 hours per day and meet the diagnostic criteria for TNS

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: * Aged between 18 and 40 years (inclusive) * Uses a mobile device for ≥3 hours/day * Reports at least 3 out of the following 6 symptoms associated with Text Neck Syndrome (TNS): Neck pain Shoulder pain Back pain Headache Insomnia Numbness/tingling in hands -Voluntarily agrees to participate and provides informed consent Exclusion Criteria: * History of congenital, traumatic, or surgical pathology affecting the cervical -------spine or shoulder region * Neurological disorders that cause headaches (e.g., migraines due to underlying neurological conditions) * Presence of inflammatory, infectious spinal diseases, or diagnosed spinal deformities * Received trigger point injections in the cervical region within the past 6 months

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Karabük University Karabük Karabük Province Recruiting

More Karabuk University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06991387 on ClinicalTrials.gov ↗ ← All trials in Turkey